ebook Munafa Stock Market Course + Intraday & FNO calls  

       

Esperion Therapeutics (ESPR) Technical (Analysis) Reports Esperion Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Complete & easy to understand technical analysis of Esperion Therapeutics (ESPR)

Technical Analysis Report for NASDAQ stock ESPR Esperion Therapeutics. Dated: 27 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange

If you are looking for Tomorrow's Movement Predictions for NASDAQ stock ESPR Esperion Therapeutics then click here. or read Experts views on Esperion Therapeutics or Forecast & share price targets of Esperion Therapeutics

Esperion Therapeutics Opened at 2.82 and Closed at: 2.74, which is -4.38% of previous session's close. It moved within a range of 2.73 and 2.84
The session was a Bearish session with an average volume of 2326100, which is -46.43% of previous session's volumes.

  • The stock has fallen, and its short term trend is also negative and in a downtrend.
  • The stock has fallen, and its mid term trend is also negative and in a downtrend.

Support for tomorrow is 2.68 and resistance for tomorrow is 2.79
These support and resistance points are valid for the first 5-15 minutes charts

Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.

Support for tomorrow's hourly charts is 2.7, 2.66 resistance for tomorrow's hourly charts is 2.81, 2.88

10 Day SMA for Esperion Therapeutics (ESPR) is 2.66 and stock is trading above these levels. This is a good sign for its short term trend

20 Day SMA for Esperion Therapeutics (ESPR) is 2.77 and the stock is trading below these levels. This is not a good sign for its mid term trend

50 Day SMA for Esperion Therapeutics (ESPR) is 3.11 and the stock is trading below these levels. This is not a good sign for its mid to long term trend

100 Day SMA is 3.31 and the stock is trading below these levels. This is not a good sign for its long term trend

200 Day SMA Esperion Therapeutics is 2.67 and stock is trading above these levels. This is a good sign for its long term trend

20 DMA of Esperion Therapeutics is at 2.77 and 200 DMA is at 2.67, while 50 DMA and 100 DMA are at 3.11 and 3.31 respectively

Esperion Therapeutics (ESPR) moving average of 20 SMA is at 2.77 and 20 EMA is at 2.8

Esperion Therapeutics (ESPR) moving average of 50 SMA is at 3.11 and 50 EMA is at 3.06

Esperion Therapeutics (ESPR) moving average of 100 SMA is at 3.31 and 100 EMA is at 3.06

Esperion Therapeutics (ESPR) moving average of 200 SMA is at 2.67 and 200 EMA is at 2.87

Xoma Corporation has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Xoma Corporation, about 36.38% more returns!

Xbiotech Inc has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Xbiotech Inc, about 18.65% more returns!

Esperion Therapeutics has performed better than Verrica Pharmaceuticals in short term. Holding Esperion Therapeutics could be a better choice for now!

Esperion Therapeutics has performed better than Veru Inc in short term. Holding Esperion Therapeutics could be a better choice for now!

Scholar Rock has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Scholar Rock, about 14.44% more returns!

Rockwell Medical has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Rockwell Medical, about 14.88% more returns!

Esperion Therapeutics has performed better than Rocket Pharmaceuticals in short term. Holding Esperion Therapeutics could be a better choice for now!

Opko Health has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Opko Health, about 11.54% more returns!

Livanova Plc has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Livanova Plc, about 5.82% more returns!

Esperion Therapeutics has performed better than Adma Biologics in short term. Holding Esperion Therapeutics could be a better choice for now!

Axsome Therapeutics has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Axsome Therapeutics, about 13.61% more returns!

Cue Biopharma has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Cue Biopharma, about 3.92% more returns!

Dare Bioscience has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Dare Bioscience, about 9.39% more returns!

Immuron has performed better than Esperion Therapeutics in short term. You could have earned much better returns by investing in Immuron, about 23.4% more returns!

Esperion Therapeutics has performed better than Iterum Therapeutics in short term. Holding Esperion Therapeutics could be a better choice for now!

Esperion Therapeutics Technical analysis of indicators

Price action analysis of Esperion Therapeutics (ESPR) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

ADX buy sell signal for Esperion Therapeutics stock for short term is BUY. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Esperion Therapeutics in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Esperion Therapeutics Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.

Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down

CCI has generated a SELL signal for Esperion Therapeutics in short term but SELL signal is weak.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Although the stock is in the SELL zone, but selling might be slowing down

Stock of Esperion Therapeutics is picking up selling momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2.65 and Esperion Therapeutics ESPR stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.

People seem to be coming out and selling the Esperion Therapeutics ESPR stock. Volume based technical analysis of Esperion Therapeutics ESPR stock is negative.

Esperion Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.

Tomorrow's Predictions

You should also read Tomorrow's Movement Predictions for NASDAQ stock ESPR Esperion Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!

And ESPR Experts View which covers a lot of information including buying and selling signals

ESPR future forecast & share price targets

You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Esperion Therapeutics or View Candle Stick Charts here

Chart Esperion Therapeutics (ESPR)  Technical (Analysis) Reports Esperion Therapeutics [

Videos related to: Esperion Therapeutics (ESPR) Technical (Analysis) Reports Esperion Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com

Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Esperion Therapeutics (ESPR)  Technical (Analysis) Reports Esperion Therapeutics [

 

Back to top